Postoperative Relapses in MS Patients
NCT04237675 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 300
Last updated 2020-01-23
Summary
The aim of the study is to record any relapses during one year postoperatively in patients and parturients diagnosed with MS who received general or regional anesthesia
Conditions
- Multiple Sclerosis Relapse
- Surgery
- Anesthesia
Interventions
- PROCEDURE
-
surgery and anesthesia
patients with MS who received general or regional anesthesia for a surgery or labor
Sponsors & Collaborators
-
University of Athens
lead OTHER
Eligibility
- Min Age
- 18 Years
- Max Age
- 70 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2019-12-20
- Primary Completion
- 2027-12-31
- Completion
- 2027-12-31
Countries
- Greece
Study Locations
More Related Trials
-
Pregnancy Cohort in Multiple Sclerosis (MS)
NCT05010902 ·Status: RECRUITING
-
Efficacy of Cyclophosphamide Versus Methylprednisolone in Patients With Secondary Progressive Multiple Sclerosis
NCT00241254 ·Status: COMPLETED ·Phase: PHASE3
-
A Study of the Safety and Efficacy of ONO-4641 in Patients With Relapsing-Remitting Multiple Sclerosis
NCT01081782 ·Status: COMPLETED ·Phase: PHASE2
-
Role of Microglia in the Pathogenesis of Progressive Multiple Sclerosis
NCT03134716 ·Status: ACTIVE_NOT_RECRUITING
-
Role of ADA SNPs in Subjects With Relapsing Multiple Sclerosis (RMS)
NCT04121065 ·Status: RECRUITING
-
Coagulation/Complement Activation and Cerebral Hypoperfusion in Relapsing-remitting Multiple Sclerosis
NCT04380220 ·Status: UNKNOWN
-
Natalizumab in Preventing Post-partum Relapses in Multiple Sclerosis
NCT03046251 ·Status: COMPLETED ·Phase: PHASE4
-
Intermittent Hypoxia Intervention in MS Patients
NCT04635033 ·Status: COMPLETED
-
Immunoadsorption vs. Plasmapheresis in the Escalation Therapy of Relapse in Multiple Sclerosis
NCT02671682 ·Status: COMPLETED ·Phase: NA
-
Adherence to Mediterranean Diet and Cardiovascular Health in Multiple Sclerosis Female Patients: a Case Control Study
NCT05175378 ·Status: COMPLETED ·Phase: NA
-
Adverse Childhood Experiences in Patients With MS: Impact on Quality of Life and on Coping Strategies Towards the Disease and Its Treatment
NCT06718920 ·Status: RECRUITING
-
Relationship Between the Nutritional Habits and Relapsing and Disability Rates in Patient With Multiple Sclerosis.
NCT04110171 ·Status: UNKNOWN
-
Frequency of FCGR3A Gene Polymorphisms in Patients With Neuromyelitis Optica Spectrum Disorders, Anti-oligodendrocyte Myelin Protein Antibody Disease, and Multiple Sclerosis.
NCT06865274 ·Status: RECRUITING ·Phase: NA
-
Immunisation Status and Safety of Vaccines in Italian MS Patients
NCT04300868 ·Status: UNKNOWN
-
Trichuris Suis Ova Therapy for Relapsing Multiple Sclerosis - a Safety Study
NCT01006941 ·Status: COMPLETED ·Phase: PHASE2
-
Development and Evaluation of a Web-based Programme on Relapse Management for People With Multiple Sclerosis
NCT04233970 ·Status: COMPLETED ·Phase: NA
-
Study to Investigate the Immune Response and Safety of Prophylactic Vaccines in Patients Treated for Multiple Sclerosis
NCT02275741 ·Status: COMPLETED
-
Safety Study of Human Neural Stem Cells Injections for Secondary Progressive Multiple Sclerosis Patients
NCT03282760 ·Status: COMPLETED ·Phase: PHASE1
-
Metacognition Assessment in Patient With Multiple Sclerosis
NCT04240379 ·Status: COMPLETED
-
Neural Stem Cell Transplantation in Multiple Sclerosis Patients
NCT03269071 ·Status: COMPLETED ·Phase: PHASE1
-
A Retrospective Study to Understand the Clinical Management of Subjects With Multiple Sclerosis at a Site in Taiwan Over the Last 10 Years
NCT01084798 ·Status: COMPLETED
-
Preliminary Study for Selective Detection of the CD8+ Myelin Specific T Cell in the Blood of Multiple Sclerosis Patients
NCT02142764 ·Status: COMPLETED ·Phase: NA
-
Finding Patterns In Clinical Study Experiences of Multiple Sclerosis Patients
NCT05503524 ·Status: NOT_YET_RECRUITING
-
Allogenic Adipose Tissue-derived Mesenchymal Stromal Cells for the Treatment of Primary Progressive Multiple Sclerosis
NCT06592703 ·Status: RECRUITING ·Phase: PHASE1
-
Autologous Mesenchymal Stem Cells From Adipose Tissue in Patients With Secondary Progressive Multiple Sclerosis
NCT01056471 ·Status: COMPLETED ·Phase: PHASE1/PHASE2